- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03697317
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
October 3, 2018 updated by: Cheryl Gibson, University of Kansas Medical Center
The improvement in morbidity and mortality observed with kidney transplantation is often curtailed by post-transplant weight gain, which is common among kidney transplant recipients (KTR).
Post-transplant weight gain is associated with serious health issues such as cardiovascular disease, new onset diabetes after transplantation, and graft failure.
Although these adverse effects of post-transplant weight gain are well recognized, interventions that target the modifiable risk factors of diet and physical activity to address post-transplantation weight gain are lacking.
The purpose of this study is to test the feasibility of an in-home, televideo health coaching to increase the healthy behaviors of KTRs who are 6 months post-transplantation.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 years or older
- Between 6 and 12 months post kidney transplantation
- Kidney allograft only
- Functioning allograft (not on dialysis)
- BMI ≥ 22 kg/m2
- Available to participate in assessments over 6 months
- Ability to speak and understand English
- Able to report data weekly by at least one of three alternative methods: telephone, email, or fax
- Access to wireless internet
Exclusion Criteria:
- Multi-organ transplant recipient
- Uncontrolled diabetes (Hemoglobin A1c≥8%)
- Currently pregnant or planning on becoming pregnant during the study
- Participation in a formal weight management, nutrition, or physical activity program
- Diagnosis of a major psychiatric illness
- Major dietary restrictions
- Inability to perform moderate to vigorous physical activity
- Unwillingness to be randomized
- Receiving supplemental nutrition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Televideo Lifestyle Coaching
|
Six month total intervention: Three months of weekly 1-hour televideo healthy lifestyle coaching sessions involving 30 minutes of structured physical activity and 30 minutes of nutrition education and daily healthy lifestyle habit tracking.
This is followed by 3 months of healthy lifestyle habit tracking only.
|
|
Active Comparator: Enhanced Usual Care
|
Six months of healthy lifestyle habit tracking with access to written diet and physical activity materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment of participants
Time Frame: 1 month
|
Achievement of 10 participants in 1 months
|
1 month
|
|
Attendance to group sessions
Time Frame: 3 months
|
Maintain 80% attendance or better to program sessions
|
3 months
|
|
Participant retention in study assessments
Time Frame: 6 months
|
85% or greater participant retention in study assessments
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in diet quality assessed by Healthy Eating Index Scores
Time Frame: Change from baseline to month 6
|
Changes in dietary quality will be determined by calculating Healthy Eating Index- 2010 scores from 3 day food records.
A total HEI-2010 score will be calculated, which is comprised of a summative score across 12 subscales, with higher scores indicative of a better diet quality (maximum score 100).
|
Change from baseline to month 6
|
|
Change in weight
Time Frame: Change from baseline to month 6
|
Weight in kilograms will be measured with a digital scale
|
Change from baseline to month 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life-Kidney Transplant Questionnaire (KTQ)
Time Frame: Baseline, 3 months, 6 months
|
Quality of life will be assessed using the Kidney Transplant Questionnaire, a 25-question disease-specific questionnaire with 5 dimensions measured- physical symptoms, fatigue, uncertainty/fear, appearance, and emotions.
A higher score indicates a greater quality of life.
A change in score greater than 0.5 in each domain is clinically significant.
|
Baseline, 3 months, 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cheryl A Gibson, PhD, University of Kansas Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 12, 2017
Primary Completion (Actual)
March 30, 2018
Study Completion (Actual)
March 30, 2018
Study Registration Dates
First Submitted
September 21, 2018
First Submitted That Met QC Criteria
October 3, 2018
First Posted (Actual)
October 5, 2018
Study Record Updates
Last Update Posted (Actual)
October 5, 2018
Last Update Submitted That Met QC Criteria
October 3, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00140695
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.